Showing all 4 results
Linagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Film-Coated Tablet, packed exclusively in highly secure Alu-Alu blister strips to ensure the absolute chemical stability of the delicate API.
Active Ingredient Strength Primary Clinical Function Linagliptin USP/Ph.Eur. 5 mg The Universal Standard: A single, high-efficacy maintenance dose that applies to all adult patients, regardless of age, hepatic function, or severe renal impairment. Excipients Mannitol / Pregelatinized Starch / Copovidone / Magnesium Stearate / Premium Opadry Film Diluent / Disintegrant / Binder / Moisture-Barrier Coating (Engineered specifically without highly hygroscopic components to prevent moisture absorption, ensuring rapid disintegration and maximum bioavailability of the 5mg payload) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Methimazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the thionamide compound.
Active Ingredient Strength Primary Clinical Function Methimazole (Thiamazole) USP/Ph.Eur. 5 mg Maintenance / Titration Standard: Base therapeutic unit for precisely lowering doses as the patient approaches the euthyroid (normal) state, preventing drug-induced hypothyroidism. Methimazole (Thiamazole) USP/Ph.Eur. 10 mg Initial Suppression Standard: High-efficacy adult therapy for rapidly crashing toxic thyroid hormone levels during severe, active hyperthyroidism. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Odor-Masking Coating (Engineered specifically using strict geometric dilution to ensure the microscopic API dose is flawlessly distributed, and fi lm-coated to mask the compound’s inherent sulfurous taste) Moxonidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micro-Dosed Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Moxonidine Ph.Eur./BP 0.2 mg Initiation / Mild Standard: Base therapeutic unit for starting therapy, specifically titrated to assess patient tolerance and prevent initial hypotension. Moxonidine Ph.Eur./BP 0.3 mg / 0.4 mg Global Cardiology Standard: High-efficacy adult maintenance dose for the aggressive management of resistant and metabolic hypertension. Excipients Lactose Monohydrate / Povidone K30 / Crospovidone / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically using strict geometric dilution protocols to ensure the microscopic API dose is flawlessly and evenly distributed throughout the entire tablet batch) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict chronic cardiology dispensing regimens).
Solifenacin Succinate Tablets
FreeA Solifenacin Succinate tablet is an antimuscarinic (anticholinergic) medication used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence.
